Showing results (61-70 of 205) with videos related to

Sort By:
Pageof 21
World Journal of Surgical Oncology|February 11, 2009
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancerEmmanuel Guardiola, Delphine Delroeux, Bruno Heyd, et al.
Current Oncology Reports|March 7, 2018
Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE SurveyJérôme Viguier, Jean-François Morère, Xavier Pivot, et al.
BMC Cancer|June 21, 2017
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC studyQuentin Jacquinot, Nathalie Meneveau, Marion Chatot, et al.
BMC Cancer|September 7, 2020
Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2- advanced breast cancer in five European countriesAlison Davie, Gebra Cuyun Carter, Alex Rider, et al.
Anticancer Research|July 31, 2012
First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysisVirginie Nerich, Fernando Bazan, Fanny Compagnat, et al.
European Journal of Applied Physiology|March 20, 2023
Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapyElyse Hucteau, Joris Mallard, Xavier Pivot, et al.
Advanced Healthcare Materials|October 28, 2021
Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple MyelomaEloise Thomas, Clélia Mathieu, Patricia Moreno-Gaona, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2006
Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancerPhilippe Fagnoni, Samuel Limat, Loïc Chaigneau, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2007
Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancerBernard Royer, Delphine Delroeux, Emmanuel Guardiola, et al.
Clinical Medicine Insights. Oncology|January 31, 2013
Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancerFabien Calcagno, Thierry Nguyen, Erion Dobi, et al.
Pageof 21